Literature DB >> 8049455

Recombinant human erythropoietin and the anemia of cancer.

J L Spivak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8049455

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

1.  Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.

Authors:  M Mittelman; D Neumann; A Peled; P Kanter; N Haran-Ghera
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  ROLE OF HAEMATOPOIETIC GROWTH FACTORS IN MEDICINE.

Authors:  Vivek Srivastava; Rajat Kumar
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 3.  Erythropoietin or darbepoetin for patients with cancer.

Authors:  Thomy Tonia; Annette Mettler; Nadège Robert; Guido Schwarzer; Jerome Seidenfeld; Olaf Weingart; Chris Hyde; Andreas Engert; Julia Bohlius
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 4.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

Review 5.  Aging and haemopoiesis. Implications for treatment with haemopoietic growth factors.

Authors:  G S Chatta; D C Dale
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 6.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 7.  A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.

Authors:  Y Beguin
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

Review 8.  Recombinant erythropoietin in clinical practice.

Authors:  T Ng; G Marx; T Littlewood; I Macdougall
Journal:  Postgrad Med J       Date:  2003-07       Impact factor: 2.401

Review 9.  Management options for cancer therapy-related anaemia.

Authors:  Tim J Littlewood
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 10.  Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.

Authors:  C J Dunn; A J Wagstaff
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.